RxDoctor Payments Data

Mark Allen, MD

Pain Medicine · Overland Park, KSNPI 1396760351

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Abbott at 35.4% of the total. Reporting peaked in 2021 at $821 and has fallen 97.8% since, to $18 in 2025. That places this record below the midpoint for pain medicine clinicians in KS, where the typical reported total is $2,519.

$2,519in general payments, 2019–2025

Across 119 payments — averaging $21.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$892
  • AbbVie$211
  • Tersera Therapeutics LLC$186
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$145
  • Precision Spine, Inc.$144
  • Baudax Bio Inc.$115
  • plus $825 from 20 others

What the payments were for

  • Food & beverage$2,48399%
  • Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,519 in reported general payments places this provider in the 50th percentile of 64 pain medicine providers in Kansas.

See all pain medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$49,114
Medicare patients
153
Services billed
541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SuboxoneBuprenorphine Hcl/Naloxone Hcl18$8,765
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen253$7,951
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen187$7,105
Oxycodone Hcl201$5,062
Morphine Sulfate ErMorphine Sulfate71$2,128
Gabapentin141$1,496
Tizanidine Hcl141$1,404
Celecoxib25$1,397
Cyclobenzaprine Hcl82$983
Pregabalin54$847
Lidocaine13$753
Morphine Sulfate24$685
Methocarbamol15$269
Duloxetine Hcl24$263
Tramadol Hcl21$246

Paid to pharmacies, not to this prescriber.

Other pain medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →